Recent evidence suggests that several unknown or ill-characterized factors strongly influence cell growth and function in culture. Isolating these factors is necessary in order to maximize culture productivities. Methylglyoxal (MG), a potent protein and nucleic acid modifying agent, has been identified as a player in the signaling pathways associated with cell death and is known to be detrimental to cultured cells. This compound is produced in all mammalian systems by spontaneous phosphate elimination from glycolytic pathway intermediates. A kinetic model that qualitatively describes the cellular distribution of proteinassociated MG in the absence of enzymatic adduct formation predicted far lower levels of reversibly bound MG than measured in cultured CHO cells. This suggests that the targeted modification of proteins through enzymatically mediated mechanisms is a significant sink for cellular methylglyoxal. The model was validated with measurements of carbon flux through the glyoxalase pathway to D-lactic acid, a unique end product of MG metabolism in mammalian systems. Fluxes to D-lactic acid of up to 16.8 mmol ml-packed cells À1 day À1 were measured with CHO cells grown in batch culture or 100-fold more than found in normal tissues.
Introduction
The ability of cultured mammalian cells to produce high titers of consistent product is influenced by many known chemical factors in the bioreactor, including media composition, nutrient concentrations, and autologously made inhibitors of cell growth and function. Major examples of the latter are the toxic by-products ammonium ion and lactate, still believed to be the principal inhibitors produced by animal cell cultures (Miller and Blanch 1991; Anderson and Goochee 1995) . It is also evident that other unknown or ill-characterized factors that strongly affect cell growth and function exist, especially in high-intensity perfusion and fed-batch cultures (Bibila and Robinson 1995) .
Methylglyoxal (MG) is a potent protein and nucleic acid modifying agent found in all mammalian systems as a consequence of energy metabolism. MG is produced through spontaneous phosphate elimination from glycolytic pathway intermediates. MG levels also respond to signaling events associated with cell death (Van Herreweghe et al. 2002) , indicating that anabolic activities for MG production may be present in mammalian systems as they are in bacteria, although that is yet to be demonstrated. The principal catabolic activity for MG is the glyoxalase pathway, which consists of glyoxalase I (GLO1; Figure 1 ) and glyoxalase II (GLO2); reduced glutathione (GSH) is a required co-enzyme for this pathway. Aldose reductases are secondary catabolic activities that become important as cellular GSH is depleted, such as under conditions of oxidative stress (Vander Jagt et al. 2001) . MGmediated cell death is tightly coupled to interactions between energy metabolism, free MG levels, reactive oxygen species (ROS), and the phosphorylation status of GLO1 (Van Herreweghe et al. 2002) . Multiple cell death pathways involving MG as a signal element appear to exist. Increased endogenous MG directly initiates cell death signaling cascades in some instances, whilst in others it occurs as a consequence of cell death activation. Specific pathway activation is cell-line dependent and results in either necrosis-or apoptosis-like end states (Du et al. 2000; Sakamoto et al. 2000; Godbout et al. 2001; Vander Jagt et al. 2001) .
Recent evidence suggests that MG is a signal molecule involved in the processes regulating apoptosis or programmed cell death (PCD). Earlier studies demonstrate that relatively small increases in the level of endogenously produced MG decrease cell viability in Chinese hamster ovary (CHO) cells (Chaplen et al. 1996a ) under growth conditions found in industrial cell culture. Here we develop a kinetic model that qualitatively describes the cellular distribution of protein-associated MG in the absence of enzymatic adduct formation. Measurements of carbon flux through the glyoxalase pathway to D-lactic acid, a unique end product of MG metabolism in mammalian systems were used to validate the model, which predicted far lower levels of reversibly bound MG than measured in cultured CHO cells. This suggests that the targeted modification of proteins by phosphorylated GLO1 or other as yet unidentified enzymatically mediated mechanisms is a significant sink for cellular MG. The model also supports observations that CHO cells have higher levels of MG than normal tissues further adding to the possible significance of MG to industrial cell cultures.
Materials and methods

Chemicals and solutions
All chemicals were of reagent grade. D-Lactate dehydrogenase (Staphylococcus epidermis), nicotinamide adenine dinucletotide (NAD + ), diethylenetriaminepentaacetic acid (DETAPAC), glycine, and D-lactate (lithium salts) were purchased from Sigma -Aldrich Co.Ltd. 5-Methylquinoxaline (5-MQ), o-phenylenediamine (o-PD) were made as previously described (Chaplen et al. 1996b ).
Cell culture
Chinese hamster ovary cells expressing recombinant tissue plasminogen activator (ATCC CRL 9606) were grown in Dulbecco's Modified Eagle Medium or D-MEM high glucose (GIBCO/ BRL/Life Technologies) as described elsewhere (Chaplen et al. 1996b) . Cell counts and cell volumes were determined as described elsewhere (Chaplen et al. 1996b ).
Methylglyoxal assay
Free MG was assayed in the medium and cells as described elsewhere (Chaplen et al. 1996b ).
D-Lactate assay
The D-lactate assay used was a modification of the D-lactate assay used for human blood samples (McLellan et al. 1992 ) and L-lactate Sigma diagnostic procedure No.826-UV (Sigma-Aldrich Co.). A 3 mg/ml stock solution of D-lactate was prepared. Hydrazine sulfate (26 mg/ml)/glycine (0.6 M) buffer was prepared and the pH adjusted to 9.2 by 5 M KOH. D-Lactate dehydrogenase solution was prepared at a concentration of 1000 U/ml just prior to use. DETPAC stock solution was made at 0.4 mg/ml in distilled water. The final assay mixture was 6 ml of 5 mg/ml NAD + in glycine-hydrazine buffer, 0.7 ml distilled water and 0.3 ml of D-lactate dehydrogenase. A 1:1 ratio of sample media and 8% (w/v) perchloric acid was mixed, incubated on ice for 10 min, and centrifuged at 4000 · g discarding any precipitate. The final assay volume was 3 ml (2.88 ml assay mixture, 20 ll DETPAC and 100 ll sample). This was incubated in a 37°C water bath for 30 min. Fluorescence was measured at 450 nm under excitation at 350 nm in a Perkin-Elmer MPF 2A Fluorescence Spectrophotometer.
D-Lactate flux assay
CHO cells were seeded at 2 · 10 6 cells per T-150 tissue culture flask in 30 ml of D-MEM high glucose. Three flasks were sacrificed at each time point (0, 4, 20, 30, 45, 65, 75, 90 h) . D-Lactate concentrations were determined as described above. The packed cell volume in each T-flask was determined as described above and used to normalize the Dlactate concentrations. D-Lactate flux was calculated as (Value at time pointÀValue at previous time point)/(Time elapsed between samples).
Rate constants for methylglyoxal degradation MG (45 mM) was incubated in 50 mM potassium phosphate buffer, pH 7.4, for 24 h at 37°C. Free MG in solution was measured at various times by derivatizing with o-PD followed by HPLC analysis (Chaplen et al. 1998 ). The first-and second-order rate constants for disappearance of MG were determined by parameter estimation.
Data analysis and kinetic modeling
Parameter estimation for determining the rate constants of MG degradation in phosphate buffer and the derivatization of MG by o-PD was done using an equation solver (Microsoft Excel, Microsoft Corp., Redmond, WA). Mathematical modeling of interactions between MG and the various amino acids was done using the numerical integration functions of the same program.
Model theory and development
Model 1: Methylglyoxal interactions with proteins in vitro
Interactions between MG and proteins were modeled because proteins are a major modification target for MG in vivo. The model was validated using experimental data originally obtained from a reaction system consisting of 100 lM MG and 1 mM bovine serum albumin (BSA) at physiological pH (7.0) and temperature (37°C) as reported in Lo et al. (1994) . The principal modification targets in proteins are arginine, lysine or cysteine residues. The amounts of arginine, lysine and cysteine present in 1 mM BSA are 2300 lM, 6100 lM and 100 lM, respectively. These numbers were derived from the amino acid sequence of BSA (Jocelyn 1977) , and by assuming an average molecular weight for BSA of 70 kDa, and for amino acid residues of 121 Da. The rate constants used in the model were those of the reaction of MG with the Na-acetylamino acid forms of each amino acid, data also taken from Lo et al. (1994) . Figure 2a shows 
The rate constants for cysteine were determined based on the concentration of the non-hydrated form of MG. The forward rate constant for the cysteine reaction (k 1 ) originally reported in Lo et al. (1994) was modified by assuming that the non-hydrated form of MG represents ca. 1.9% of the total free MG concentration at equilibrium. The rate constants for arginine and lysine were determined based on the total free MG concentration. The degradation and dimerization of free MG that occurs under the conditions of the reported study must also be accounted for to provide good agreement with the in vitro data. The kinetics of MG degradation was determined as described above. MG degradation was modeled as combined first order (degradation) and second order (dimerization) reactions. The rate constant for degradation was k deg = 3.0 · 10 À6 s À1 ; the rate constant for dimerization was k dim = 4.9 · 10 À4 M À1 s
À1
. Equations (1)- (9) show the model in differential equation form. C 1 is the hemithioacetal formed between Na-acetylcysteine and MG; A 1 is Na-acetylarginine-MG glycosylamine; A 2 is 4,5-dihydroxy-5-methylimidazolidine; L 1 is N a-acetyllysinemethylglyoxal glycosylamine; L 2 is bis(Na-acetyllysine)methylglyoxal glycosylamine.
An understanding of the tertiary structure of BSA in solution was also important for maximizing agreement between the model and the available data. BSA in solution is conformationally dynamic (Jocelyn 1977) , which would effectively expose most residues to MG modification. Therefore, all arginine and lysine residues were treated as being available for reaction with MG. Most cysteine residues in BSA are in the cystine form as they are involved in disulfide bond formation. The number reported for free cysteine residues is generally one (Jocelyn 1997) . Model predications for reversibly bound MG were the sum of cysteine and the initial modification steps for arginine and lysine. Secondary reactions at arginine and lysine residues are effectively irreversible based on the available rate constant data and described secondary structures (Bourajjaj et al. 2003) .
Model 2: Methylglyoxal interactions with proteins in vivo
The model described in the previous section was extended to consider interactions between intracellular proteins and MG. The total concentrations of arginine, lysine and cysteine present in the cell were assumed 70.5 lmol ml-packedcell À1 , 105 lmol ml-packed-cell À1 and 39.74 lmol ml-packed-cell À1 , respectively. The concentration of each amino acid was determined from the overall amino acid composition of proteins in animal cells (Xie and Wang 1994) . To determine the cysteine residue concentration, the ratio of cysteine to cystine residues (11.5:1) was taken to be the average of the reported ratios for 85 enzymes and other proteins (Jocelyn 1977) . The protein concentration in animal cells is approximately 180 g/l (Alberts et al. 1994) and this was used, along with an average amino acid molecular weight of 121 Da, to determine the overall amino acid concentrations. The degradation of MG present in the Model 1 was neglected since this term is negligible at the low free MG concentrations present in the cell.
Three additional terms were added to Model 1 to account for MG metabolism. Figure 2b shows terms for MG production, MG catabolism by the glyoxalase pathway and MG-modified protein degradation or turnover. MG production was treated as a simple zero order term. MG catabolism by the glyoxalase pathway was assumed to follow Michaelis-Menten kinetics. V max for glyoxalase I was estimated based on measured activities from cultured CHO cells (310 lmol-product/(min mg-total-protein); Chaplen et al. 1996a), K m was the average of several reported K m for mammalian systems (200 lM; Thornalley 1990 ). The true substrate for glyoxalase I is the hemithioacetal formed between MG and reduced glutathione. K eq for hemithioacetal formation has been measured as 333 M À1 (Vander Jagt et al. 1972) . Reduced glutathione was assumed present at the same level as for red blood cells (2 lmol ml-packed-cell À1 ; Thornalley 1990). V max for glyoxalase II was estimated based on the measured activities for CHO cells (30 lmol-substrate consumed/(min mg-total-protein); this study), K m was the average of several reported K m for mammalian systems (230 lM; Thornalley 1990 ). Finally, protein degradation or turnover rate was assumed first order in protein concentration, with the turnover rate constant, k t . The model in differential equation form consisted of Equations (10)- (20) . MGA in Equation (10) is the MG produced through MG anabolism; HTA is the hemithioacetal substrate of glyoxalase I. SLG in equations (11 and 12) is the product of the glyoxalase I reaction (S-Dlactoylglutathione) and DL in equation (12) is the product of the glyoxalase II reaction (D-lactate).
Results
Modeling MG interactions with proteins in vitro
MG, a biogenic dicarbonyl that has been directly linked to adducts or advanced glycation endproduct (AGE) formation in human tissues Ahmed et al. 1997; Uchida et al. 1997; Shinohara et al. 1998 ) and has recently been identified (along with glyoxalase I) as a key regulator of necrotic cell death in fibrosarcoma L929 cells (Van Herreweghe et al. 2002) . This compound at the cellular level exists as a complex and heterogeneous mixture of free and bound forms. Proteins are a major target of MG and are modified in a series of reversible (bound MG considered to be in dynamic equilibrium with free MG at cellular time-scales) and irreversible reactions at cysteine, arginine and lysine residues. Hemithioacetal formation at cysteine residues is reversible (Lo et al. 1994) , although recent evidence suggests that irreversible cysteine-derived adducts form under physiological conditions and are enzymatically mediated (Van Herreweghe et al. 2002) . Arginine and lysine modification results in AGE formation via Schiff's base and Amadori rearrangement product intermediates and is believed to be an important signal for senescent protein degradation (Westwood and Thornalley 1996) . The initial reaction steps are reversible and involve non-enzymatic Schiff's base formation between the aldehyde or ketone moiety of MG and protein amine groups (Shamsi et al. 1998) , followed by a rearrangement to more stable, covalently bonded Amadori products. These then undergo further irreversible rearrangements to form AGEs with a broad range of structures.
The first model developed and tested (Model 1; Schematic in Figure 2a ) considered MG-protein interactions in vitro. The model was tested with data from the study of Lo et al. (1994) . This study measures, as a function of time, the relative levels of irreversibly bound, reversibly bound, free and degraded MG present in an in vitro systemconsisting of MG (100 lM) and BSA (1 mM) at physiological pH and temperature. In this instance, irreversibly bound is a functional definition that represents the MG that has gone through a second reaction step with Arginine and Lysine (MG-Arg 2 and MG-Lys 2 in Figure 2a ). Reversibly bound MG represents the MG associated with cysteine and involved in the first reaction step with Figure 3 . Model predictions for reaction of methylglyoxal (1 mM) with BSA (100 lM) at physiological pH and temperature. Data (symbols) were obtained from Lo et al. (1994) and are compared with Model #1 predictions (lines) for reaction of MG in this system. For modeling purposes, BSA is treated as a pool of free arginine, lysine and cysteine at concentrations of 2300 lM, 6100 lM and 300 lM, respectively. (a) Degraded MG (1) and free MG (2); (b) irreversibly bound MG (3) and reversibly bound MG (4).
Arginine and Lysine (MG-Cys, MG-Arg 1 and MG-Lys 1 in Figure 2a) . Figure 3a shows a comparison of the experimental and predicted levels for free and degraded MG. Figure 3b shows a comparison of the experimental data and the model predictions for irreversibly and reversibly bound MG. Free MG represents MG that remains free and in solution, whether in hydrated or non-hydrated form. Degraded MG represents MG that either spontaneously degraded or dimerized during the course of the original study. Both free and degraded MG were given as model outputs and could be directly compared with experimental results.
Equilibrium constant data for MG interactions with the Na-acetylamino acid forms of arginine, lysine and cysteine were obtained from the literature (Lo et al. 1994 ). The assumption made in using these data was that it would provide a reasonable approximation of interactions between MG and the various amino acid residues. This assumption is less than optimal when considering specific amino acid residues. For example, the equilibrium constant for the MG:Na-acetylcysteine interaction (K equil = 5.6 · 10 6 M À1 ; Lo et al. 1994 ) differs significantly from that of MG:reduced glutathione (K equil = 2.8 · 10 5 M À1 ; Creighton et al. 1988 ), a tripeptide containing cysteine. However, if the average equilibrium between MG and the pool of available amino acid residues is considered, this assumption appears reasonable as shown in Figure 3 .
Modeling the fate of intracellular MG
Model 1 was extended to include aspects of MG metabolism in cultured cells (Model 2; Schematic in Figure 2b ). Intracellular free MG exists as a complex function of cell metabolism and interactions with cellular structures, in particular, proteins (Chaplen et al., 1998) . MG:protein interactions form the central element of Model 2 (Figure 2b ), where they are treated similarly to Model 1, but with the arginine, lysine and cysteine residue concentrations adjusted to reflect the protein content and composition of mammalian cells. Model 2B only accounts for spontaneously formed MG adducts. Additional terms representing MG anabolism and catabolism, and protein turnover were also added. The resulting model predicts the a Samples were derivatized at 20°C in PCA (0.45 M) for 24 h with o-PD and then analyzed for 2-MQ content by HPLC. Each datapoint represents mean ±2r; n = 6. See (Chaplen et al., 1998) .
effect of step changes in MG anabolism on bound and free intracellular MG levels. MG anabolism was assumed to be zero order and was set at 5000 lmol ml-packed-cell À1 day À1 based on experimental measurements of D-lactate flux in CHO cells. MG catabolism was assumed to be via the glyoxalase pathway alone since order-of-magnitude estimates have indicated that 10-to 40-fold more MG is detoxified by the glyoxalase system than by aldose reductase in most human tissues (Thornalley 1996) . Kinetic data for modeling the glyoxalase I reaction was derived from measurements of specific activity in CHO cells (Chaplen et al. 1996a ) and by averaging reported k m data from various mammalian cell types (Thornalley 1990) . Protein turnover was considered first order in protein concentration and was set to give an average protein life of 1 day (k t = 1.16 · 10 À5 s À1 ). Figure 4 shows the level of free, reversibly and irreversibly bound MG predicted by the model using the definitions above. The steady-state concentration of free MG was 0.035 lmol L-packedcell À1 ; the steady state concentration of reversibly bound MG was 3 lmol L-packed-cell À1 ; the steady state concentration of irreversibly bound MG was 1.3 lmol L-packed-cell À1 . These levels of reversibly bound MG were 1-2 orders of magnitude lower than found in CHO cells in culture (Table 1; Chaplen et al. 1998) .
In normal tissues, long-lived proteins, such as eye lens crystallin, accumulate AGEs with age (Ahmed et al. 1997) . Even short-lived proteins, such as hemoglobin, can accumulate AGEs, although at lower levels (Makita et al. 1992) . The steady state concentration of irreversibly bound MG increased with decreased protein turnover but did not exceed 10 lmol L-packed-cell À1 even for an average protein life of 100 days.
MG metabolism dynamics in batch culture
The predicted flux to D-lactate for normal tissues is on the order of 500 lmol ml-packed-cell À1 day À1 Figure 5 . Change in medium and cellular MG levels for CHO cells in batch culture. CHO cells were cultured in T-150 tissue culture flasks. Cells were seeded at 2.0 · 10 6 cells per flask and cell growth measured through cell counts. Media measurements show consistent levels of free MG present in the system. Cell measurements showed an increase in reversibly bound MG during exponential growth phase and a significant decrease during lag phase. Cell samples were incubated in PCA for 10 min and the resulting precipitate was removed by centrifugation (25,000 · g; 10 min). Samples were derivatized at 20°C for 4 h with o-PD and then analyzed for 2-MQ content by HPLC as described. e D-Lactic acid production was calculated as (Value at t 2 -Value at t 1 )/(t 2 À t 1 ) from previous column.
f Calculated value was less than zero. (Richard 1991) . The measured value for red blood cells is 125 lmol ml-packed-cell À1 day À1 (Thornalley 1988). The predicted steady state values for free MG ($0.003 lmol L-packed-cell À1) for this study at 500 lmol ml-packed-cell À1 day À1 D-lactic acid produced were an order of magnitude below that measured for CHO cells in culture. In addition, levels of bound MG were 2-3 orders of magnitude below those recovered using an assay for reversibly bound MG (Chaplen et al. 1998 ; Table 1 ). Table 2 reports measurements of D-lactic acid flux in CHO cells grown in culture ranged from 15.8 mmol ml-packed-cell À1 day À1 in lag phase to 0 mmol ml-packed-cell À1 day À1 in stationary phase and were greatest in lag and early exponential phase. Table 2 also reports measurements for medium MG -representative of free MG levels in cell increased during exponential and late stationary phase and ranged from 0.03± 0.01 to 0.19±0.04 lmol L-packed-cell À1 (mean±std. dev; n = 4). Medium measurements of free MG are better predictors of cellular MG levels because MG is freely membrane permeable and the assay for free intracellular MG also captures some reversibly bound MG. The predicted levels of free MG were consistent with these values (0.03-0.1 lmol L-packed-cell À1 ). However, the predicted values for bound MG (maximum 10 lmol L-packed-cell À1 at an average protein life of 100 days) were still 1-2 orders of magnitude the values observed from the assay for reversibly bound MG. Figure 5 shows measurements for free cellular MG in relation to the culture phasewhich capture both free and some reversibly bound MG ranged from 0.1±0.03 to 1.9±0.03 lmol L-packed-cell À1 (mean± std. dev; n = 4) with a maximum in exponential phase growth. These values are higher than those reported for the medium because the intracellular assay for free MG also captures some reversibly bound MG (Chaplen et al. 1996b ).
Discussion
The culturing of mammalian cells is an important technology for the commercial production of high value proteins, such as interleukins, interferon, tissue plasminogen activator and monoclonal antibodies. Cell lines must provide a consistent product and high specific productivities for long periods of time. Premature cell death in industrial cell cultures represents a significant loss of valuable resources and has important consequences for overall process productivity. Much effort is focused on enhancing cell survival in industrial cell culture with various genetic, chemical or nutritional approaches. High levels of reversibly bound MG can be recovered from CHO cells grown in culture (AGE and AGE precursors) . Furthermore, CHO and other cell-lines used in industrial cell culture contain many of the elements (signal molecules, kinases, receptors) reported to participate in the MG-dependent cell death pathways, and the negative effects of endogenous MG accumulation on CHO cell viability is demonstrated. Previous studies to model MG metabolism focused on the kinetics of the glyoxalase system (cf. Creighton et al. 1988; Martins et al. 2001) . In this work, a kinetic model that qualitatively describes the distribution of spontaneously reacting MG with proteins was developed and validated in order to better understand MG metabolism in cultured CHO cells.
MG modification of cellular proteins
Model 1 allowed validation of the general approach for modeling spontaneous modification of protein amino acids. Model 2 models the spontaneous formation of protein:MG AGEs in cellular systems. The spontaneous formation of AGEs may have significant implications for cell function in culture due to the MG-mediated cell death pathways. AGE-modified proteins are antigenic and provoke cellular injury responses upon endocytosis by cell-surface receptors. Several MG-derived AGEs have been identified, including N e -(carboxyethyl)-lysine (CEL), MG-lysine dimer (MOLD), argpyrimidine, and 5-methylimidazolone (Bourajjaj et al. 2003) . Cysteine modification results in the formation of a highly unstable hemithioacetal, which then may be transformed to irreversible AGE-like adducts, a reaction mediated by phosphorylated GLO1 (Van Herreweghe et al. 2002) . MG modification of N-terminal amino acids results in their rapid deamination ((Takahashi 1968) . Modification of nucleic acids occurs principally at guanyl bases (Vaca et al. 1994) , and results in gene mutation and abnormal gene expression patterns (Papsoulis et al. 1995) . Oxi-dative stress, mediated through ROS, magnifies the mutagenicity of MG many-fold. Little is yet understood about interactions between intracellular metabolic fluxes and fluxes to individual AGES.
MG and cell death
MG metabolism is 1-2 orders of magnitude more active in CHO cells during certain phases of batch culture than in normal tissues. A high rate of detoxification during lag phase is evident from Table 2 . Low rates of detoxification occur during stationary phase. These results are consistent with the possible role of MG in modulating cell growth and function in batch culture. The level of reversibly bound MG predicted by Model 2 is 1-2 orders of magnitude less than that measured using an assay designed to capture reversibly bound MG (Table 1 ). This suggests that much of the MGderived adduct formation that occurs in the cell is tightly regulated and involved in the regulation of cellular activities.
The link between endogenous MG and cell death is firmly established in several cell lines (Jurkat leukemia, HL60, human myeloma U266, murine fibrosarcoma L929). The cellular machinery associated with MG-mediated cell death has only been partially elucidated, however. MGmediated cell death in L929 cells is initiated through TNF-a binding to cell surface receptors. The process in L929 cells is caspase independent and characterized by mitochondrial accumulation of ROS (Van Herreweghe et al. 2002) . Activation of protein kinase A (PKA) by TNF-a leads to phosphorylation of GLO1. Increased MG anabolism is also evident in L929 cells exposed to TNF-a resulting in increased levels of endogenous MG. Phosphorylated GLO1 then modifies specific and as yet unidentified protein sites in the cell to form novel AGE's. The structure of these modifications has not been elucidated. Basal levels of phosphorylated GLO1 are always present in the cell, but increased levels are generated in response to cellular exposure to TNF-a. Addition of anti-oxidants significantly decreases the level of GLO1-mediated cell death indicating that mitochondrial ROS accumulation plays a critical role. Considerable 'cross-talk' between the various signaling pathways associated with MG and cell death in L929 cells is also evident. Caspase inhibitors block Fas-mediated apoptotic death in L929 cells but ultimately result in necrotic cell death mediated through accumulation of ROS. Inhibition of caspase activities sensitizes the cells to TNF-a-mediated necrotic cell death. Caspases may have a role as negative regulators of TNF-a-induced radical formation in the mitochondria of L929 cells. Oxidative damage to intracellular proteins increases their susceptibility to proteolysis. A low level of caspase activity may be beneficial to the cell imparting protection to mitochondria damaged by increased levels of ROS.
There are also reports of the mechanisms of MG-mediated cell death in other cell lines that give strong indications of involvement in cell death processes in general. MG modification prevents Hsp27 oligomerization followed by cytochrome c-mediated caspase activation and apoptotic cell death in human leukemia U937 cells (Sakamoto et al. 2000) . MG-mediated cell death in the human myeloma cell line U266 contrasts with that in L929 cells in that it is caspase dependent, although it does not involve the mitogen activating protein (MAP) kinase pathway. Rather, activation of protein kinase C (PKC) by MG leads to ROS accumulation and apoptotic cell death. PKC activation is not dependent on the presence of ROS. MG-mediated cell death in the human Jurkat leukemia cell line is also caspase dependent (8). Activation of c-Jun N-terminal kinase (JNK) by MG leads to caspase-3 activation and subsequent apoptosis. Inhibition of JNK by curcumin or expression of a dominant negative mutant of JNK protected the cells from MG-induced apoptosis. Finally, increased levels of endogenously produced MG have been associated with apoptosis in HL60 cells exposed to the GLO1 inhibitor diester S-pbromobenzylglutathione diester (BBGD; Thornalley et al. 1996) . This contrasts with the increase in necrosis noted in L929 cells after exposure BBGD.
Conclusions
Mammalian cell culture is an important technology for the production of therapeutic proteins. Cells grown in culture produce a number of toxic by-products that are known to reduce cell productivity. Two major inhibitory waste-products are L-lactate and ammonium ion. MG is a less well-known inhibitory compound, found in mammalian systems as a consequence of glycolysis and other anabolic processes. MG is of potential biotechnological interest because it is a potent protein and nucleic acid modifying agent and a cause of general oxidative stress, producing ROS. The majority of intracellular MG (>99%) is associated with macromolecules, particularly proteins and nucleic acids. Endogenously produced MG is a mediator in certain cell death pathways. Kinetic modeling results from this study suggest that most bound MG is non-spontaneously associated with proteins.
